Health Law

Read Mergers & Acquisitions Law updates, articles, and legal commentary from leading lawyers and law firms:

News & Analysis as of May 21, 2013

How to Minimize FCPA Risk in Health Care Acquisitions

by Mintz Levin - Health Law on 5/10/2013

When acquiring a health care company doing business abroad, there is no such thing as being too thorough with anti-corruption due diligence. The Department of Justice and the Securities and Exchange Commission have the...more

Investigation of Merger of PROLOR Biotech and OPKO Health FAQ

by Wohl & Fruchter LLP on 4/29/2013

We are investigating the proposed merger of PROLOR Biotech, Inc. (PROLOR) (NYSE: PBTH) with OPKO Health, Inc. (OPKO). As set forth in our FAQ, our investigation concerns whether approval of the transaction was improperly...more

Pharmaceutical Anti-Corruption Compliance Conference In Philadelphia December 11-12

by Thomas Fox on 12/4/2012

The pharmaceutical; medical device and medical supply industry have all been hit hard by Foreign Corrupt Practices Act (FCPA) enforcement actions. Just this summer, enforcement actions were announced against Pfizer which...more

China Life Sciences and Health Industry Client Briefing – September 2012 (October 4, 2012)

by Reed Smith on 10/5/2012

In This Issue: • Merck-Simcere Joint Venture Starts Business in Pudong (Shanghai Daily 2012-09-13) – September 14, 2012 • Pfizer Joint Venture Set to Hire 600 Staff (Bloomberg News 2012-09-14) – September 14,...more

Are Prosecutors Pushing the Envelope Too Far?

by Michael Volkov on 1/19/2012

Federal prosecutors continue their aggressive enforcement of criminal laws against companies and individuals using aggressive investigative techniques, novel theories and new strategies which are testing the limits of due...more

Anti-Corruption Risks for Private Equity -- Portfolio Companies

by Michael Volkov on 1/18/2012

The Justice Department and the SEC are targeting private equity companies for anti-corruption enforcement. Private equity companies are most at risk in their ownership of private equity companies....more